LYRM4 and neoplasm: Here, we developed a prognostic signature with DRL consisting of six disulfidptosis-related lncRNAs (LINC00641, AL139232.1, AL390775.1, LEF1-AS1, LYRM4-AS1, and AL691432.4), some of which have been associated with tumor progression.